ESO Solutions gets a “strategic” investment (apparently some lack strategy, which I can believe) from PE firms to support growth for its emergency services EMR.
Another drug company service firm, CRO Medpace, is seeking to go public and raise as much as $151 million.
http://www.fiercebiotech.com/cro/medpace-seeks-151m-ipo-says-cro-industry-worth-31b-by-decade-s-end?utm_medium=nl&utm_source=internal&mrkid=635530&mkt_tok=eyJpIjoiWkRCaU9HSTBNek5sWVRaaiIsInQiOiJwa2Vpa1FZY05nN2V4b1hiS0dsWE42MEswMmNCVFYrMzVHRWloYVVBZnA3cFlyRU1xTVJET0NBQW9sd3JFTGUxYnJZOHprUWV6RFNOVXZrMzBFZkFidzNQVTU5YXh5Z1FVbTlFYmxxQnlYVT0ifQ%3D%3DDrug marketing service firm Inventiv has cancelled its return as a public company, instead taking a huge investment from a PE firm.
http://www.fiercebiotech.com/cro/inventiv-cancels-ipo-as-it-announces-major-investment-from-advent?utm_medium=nl&utm_source=internal&mrkid=635530&mkt_tok=eyJpIjoiWkRCaU9HSTBNek5sWVRaaiIsInQiOiJwa2Vpa1FZY05nN2V4b1hiS0dsWE42MEswMmNCVFYrMzVHRWloYVVBZnA3cFlyRU1xTVJET0NBQW9sd3JFTGUxYnJZOHprUWV6RFNOVXZrMzBFZkFidzNQVTU5YXh5Z1FVbTlFYmxxQnlYVT0ifQ%3D%3DThe FDA issues final guidance on general wellness products, affirming that most will be exempt from any regulation.
Read More
In research from Sweden, privatizing certain health services appeared to lead to better quality.
Read More